About Nymbl Science
Nymbl Science is a private company based in Denver, Colorado. It has reported $15,781,533 raised in four offerings on Form D since July 2019.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 29, 2025 | Sep 12, 2025 | $984,057of $2.3M target | 30 | $32,802 | Debt, Equity issuable upon conversion of debt.Rule 506(b) | Form D ↗ |
| Oct 17, 2022 | Dec 1, 2022 | $8,752,476of $13.0M target | 23 | $380K | EquityRule 506(b) | Form D ↗ |
| Sep 24, 2020 | Oct 7, 2020 | $3,720,000of $3.9M target | 22 | $169K | EquityRule 506(b) | Form D ↗ |
| Jun 27, 2019 | Jul 12, 2019amended Aug 1, 2019 | $2,325,000of $2.6M target | 27 | $86,111 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, four offerings | $15,781,533 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Nymbl Science's Form D filed Sep 12, 2025.
TV
Thomas Virden
Director
BW
Ben Wire
Director
EL
Edward Likovich
Executive officer and director
CS
Chris Saxman
Director
RS
Rohit Seth
Director
MO
Meghan Oliver
Director
DE
David Eichler
Director
Earlier filings also listed Philip Linville (director, last listed Dec 2022), James Cook (director and promoter, last listed Oct 2020), Dr. Jean-Pierre Farcy (promoter, last listed Oct 2020), Caroline Owen-Jones (promoter, last listed Oct 2020) and Carol Jones (promoter, last listed Aug 2019).